Back to NBIX
VANGUARD GROUP INC NBIX Position History
Neurocrine Biosciences, Inc. • Healthcare
Quarters held
20
Latest value
$87.9M
Q4 2025
Peak value
$1.3B
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $5.6M |
| Q1 2025 | $1.1B |
| Q1 2025 | $4.2M |
| Q1 2025 | $4.5M |
| Q1 2025 | $2.8M |
| Q2 2025 | $6.2M |
| Q2 2025 | $1.2B |
| Q2 2025 | $4.9M |
| Q2 2025 | $5.2M |
| Q2 2025 | $3.1M |
| Q3 2025 | $1.3B |
| Q3 2025 | $7M |
| Q3 2025 | $5.6M |
| Q3 2025 | $6M |
| Q3 2025 | $82M |
| Q4 2025 | $7M |
| Q4 2025 | $1.3B |
| Q4 2025 | $5.6M |
| Q4 2025 | $6.1M |
| Q4 2025 | $87.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q4 2025 | $87.9M | 619.9K | — | — |
| Q4 2025 | $6.1M | 42.9K | — | — |
| Q4 2025 | $5.6M | 39.6K | — | — |
| Q4 2025 | $1.3B | 8.95M | — | — |
| Q4 2025 | $7M | 49.6K | — | — |
| Q3 2025 | $82M | 584.0K | — | — |
| Q3 2025 | $6M | 42.9K | — | — |
| Q3 2025 | $5.6M | 39.8K | — | — |
| Q3 2025 | $7M | 49.6K | — | — |
| Q3 2025 | $1.3B | 8.99M | — | — |
| Q2 2025 | $3.1M | 24.3K | — | — |
| Q2 2025 | $5.2M | 41.2K | — | — |
| Q2 2025 | $4.9M | 38.8K | — | — |
| Q2 2025 | $1.2B | 9.65M | — | — |
| Q2 2025 | $6.2M | 49.6K | — | — |
| Q1 2025 | $2.8M | 25.4K | — | — |
| Q1 2025 | $4.5M | 41.1K | — | — |
| Q1 2025 | $4.2M | 38.4K | — | — |
| Q1 2025 | $1.1B | 9.79M | — | — |
| Q1 2025 | $5.6M | 50.5K | — | — |
Other funds holding NBIX
$997.5M
$967.6M
$941.2M
$917.9M
$900M
$781.2M
$780M
$739.1M